Nicholas Sumas has served as a Director since 2009, and has been a Co-President since 2018. Mr. Sumas has held a diversity of supervisory positions since his employment in 1994, including Chief ...
announced today that Steve Gutterman has been appointed as ChiefExecutiveOfficer and Jimmy Vaipoulos as Chairman of the board of directors (the "Board"). Mr. Gutterman becomes CEO after ...
Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced the appointment of Matthias Will, M.D., as Chief ...
The Wendy's Company (Nasdaq: WEN) ("Wendy's" or the "Company") announced today the appointment of John Min as the Company's Chief Legal Officer and Secretary and Mary Greenlee as Senior Vice President ...